Plant lipids that lower serum cholesterol

European Heart Journal

Volumn 20, Issue 21, 1999, Pages 1527-1529

  Van Den Brand, M ^a   Laarman, G J ^b   Steg, P G ^c   De Scheerder, I ^d   Heyndrickx, G ^e   Beatt, K ^f   Kootstra, J ^g   Simoons, M L ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

^c BICHAT HOSPITAL   (France)

^d UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^e Onze Lieve Vrouw Ziekenhuis   (Belgium)

^f CHARING CROSS HOSPITAL   (United Kingdom)

^g CARDIALYSIS   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CAMPESTEROL; CHOLESTEROL; HYPOCHOLESTEROLEMIC AGENT; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MARGARINE; NEOMYCIN; PHYTOSTEROL; SIMVASTATIN; SITOSTANOL; SITOSTEROL;

ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG MECHANISM; EDITORIAL; HUMAN; HYPERCHOLESTEROLEMIA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ANTICHOLESTEREMIC AGENTS; CHOLESTEROL, LDL; DIETARY SUPPLEMENTS; ESTERS; HUMANS; MARGARINE; SITOSTEROLS;

EID: 0345581427     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.1999.1824     Document Type: Editorial

References (22)

1. Theroux P, Quimet H, McCans J. Aspirin, heparin, or both to treat acute unstable angina. N Engl J Med. 319:1988;1105-1111.
2. van Miltenburg-van Zijl A, Simoons ML, Veerhoek RJ, Bossuyt PM. Incidence and follow-up of Braunwald subgroups in unstable angina pectoris. J Am Coll Cardiol. 25:1995;1286-1292.
3. Goldman BS, Katz A, Christakis G, Weisel R. Determinants of risk for coronary artery bypass grafting in stable and unstable angina pectoris. Can J Surg. 28:1985;505-508.
4. de Feyter PJ, Suryapranata H, Serruys PW. Coronary angioplasty for unstable angina: immediate and late results in 200 consecutive patients with identification of risk factors for unfavorable early and late outcome. J Am Coll Cardiol. 12:1988;324-333.
5. van den Brand MJBM, Simoons ML, de Boer MJ, van Miltenburg A, van der Wieken LR, de Feyter PJ. Antiplatelet therapy in therapy - resistant unstable angina. A pilot study with REO-PRO (c7E3). Eur Heart J. 16:1995;36-42.
6. N Engl J Med. 330:1994;956-961.
7. Lancet. 349:1997;1429-1435.
8. Ryan TJ, Faxon DP, Gunnar RM. Guidelines for percutaneous transluminal coronary angioplasty: A report of the American College of Cardiology/American Heart Association Task Force on assessment of diagnostic and therapeutic cardiovascular procedures (Subcommittee on percutaneous transluminal coronary angioplasty). J Am Coll Cardiol. 12:1988;529-549.
9. Chesebro JH, Knatterud G, Roberts R. Thrombolysis in myocardial infarction (TIMI) trial, Phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase*. Clinical findings through hospital discharge. Circulation. 76:1987;142-154.
10. Braunwald E. Unstable angina. A classification. Circulation. 80:1989;410-414.
11. Capone G, Wolf MM, Meyer B, Meister SG. Frequency of intracoronary filling defect by angiography in angina pectoris at rest. Am J Cardiol. 56:1985;:403-6.
12. den Heyer P, Foley DP, Escaned J. Angioscopic versus angiographic detection of intimal dissection and intracoronary thrombus. J Am Coll Cardiol. 24:1994;649-654.
13. N Engl J Med. 336:1997;1689-1696.
14. Circulation. 96:1997;1445-1453.
15. Lancet. 349:1997;1422-1428.
16. Muhlestein JB, Karagounis LA, Treehan S, Anderson JL. 'Rescue' utilization of abciximab for the dissolution of coronary thrombus developing as a complication of coronary angioplasty. J Am Coll Cardiol. 30:1997;1729-1734.
17. Xue-Qiao Zhao, Snapinn S, Sax FL. Angiographic results from platelet receptor inhibition for ischemic syndrome management in patients with documented unstable angina or non Q wave MI (PRISM-plus) (Abstr). Circulation. 96:1997;I-474.
18. Ellis SG, Lincoff AM, Miller D. Reduction in complications of Angioplasty with Abciximab occurs largely independently of baseline lesion morphology. J Am Coll Cardiol. 32:1998;1619-1623.
19. Kereiakes D, Lincoff AM, Miller DP. Abciximab therapy and unplanned coronary stent deployment. Favourable effects on stent use, clinical outcomes, and bleeding complications. Circulation. 97:1998;857-864.
20. Lancet. 352:1998;87-92.
21. Anderson HV, Kierkeeide RL, Krishnaswami A. Cyclic flow variations after coronary angioplasty in humans: clinical and angiographic characteristics and elimination with 7E3 monoclonal antiplatelet antibody. J Am Coll Cardiol. 23:1994;1031-1037.
22. Ellis SG, Vandormael MG, Cowley MJ. Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease: Implications for patient selection. Circulation. 82:1990;1193-1202.